机构:[1]School of Life Sciences, The Chinese University of Hong Kong, Shatin, N.T, 999077, Hong Kong, China[2]College of Pharmaceutical Sciences, Hebei University, Baoding, 077000, China[3]Li Dak Sum Yip Yio Chin R&D Centre for Chinese Medicine and State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants (CUHK), The Chinese University of Hong Kong, Shatin, N.T, 999077, Hong Kong, China[4]SUSTech Core Research Facilities, Southern University of Science and Technology, Shenzhen, 518000, China[5]China National Analytical Center, Guangzhou Institute of Analysis, Guangdong Academy of Sciences. Guangzhou, 510000, China[6]The Second Clinical Medical College, Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China广东省中医院[7]Guangzhou Key Laboratory of Chirality Research on Active Components of Traditional Chinese Medicine, Guangzhou, 510006, China[8]Guangdong Provincial Key Laboratory of Chemical Measurement and Emergency Test Technology Institute of Analysis, Guangdong Academy of Sciences, China National Analytical Center, Guangzhou, China[9]Cardiovascular Institute, School of Medicine, Stanford University, California, USA
Ethnopharmacological relevance: Fu Rong Ye (FRY), the leaf of Hibiscus mutabilis L., is a Chinese medicinal herb used to treat coughs and respiratory diseases. FRY is the major herbal component of the patent medicine Fupo Ganmao Granules for treating common cold. However, its anti-influenza active components and mechanism were not identified.Aim: Here, we aim to a) isolate the anti-influenza phytochemicals from FRY extract and b) explore its anti-flu mechanism.Material and methods: Bioassay guided isolation was performed to get anti-influenza virus components. Influenza virus infected cells and mouse model were employed for efficacy evaluation. Results: Using bioassay-guided isolation, the flavonoid tiliroside was obtained, which inhibited four IAV strains in MDCK cells with EC50 ranging from 3.87 to 27.61 mu M by suppressing the viral ribonucleoprotein activity. Tiliroside also significantly downregulated the expression of cytokines/chemokines in A549 cells, and protected 50% of PR8-infected BALB/c mice from death and at 800 mg/kg/day, improved lung edema conditions.Conclusion: Tiliroside is effective for influenza virus infection treatment and promising for further drug devel-opment. This study is the first to demonstrate that tiliroside in FRY acts against influenza virus.
基金:
Health and Medical Research Fund of HKSAR; Hong Kong Scholars Programme; special foundation of Guangzhou Key Labo- ratory; Guangdong Academy of Sciences; [19180302]; [XJ2020041]; [202002010004]; [2020GDASYL-20200103046]
第一作者机构:[1]School of Life Sciences, The Chinese University of Hong Kong, Shatin, N.T, 999077, Hong Kong, China
共同第一作者:
通讯作者:
通讯机构:[1]School of Life Sciences, The Chinese University of Hong Kong, Shatin, N.T, 999077, Hong Kong, China[3]Li Dak Sum Yip Yio Chin R&D Centre for Chinese Medicine and State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants (CUHK), The Chinese University of Hong Kong, Shatin, N.T, 999077, Hong Kong, China[5]China National Analytical Center, Guangzhou Institute of Analysis, Guangdong Academy of Sciences. Guangzhou, 510000, China[*1]School of Life Sciences, The Chinese University of Hong Kong, Hong Kong, China[*2]China National Analytical Center, Guangzhou Institute of Analysis, Guangdong Academy of Sciences, China.
推荐引用方式(GB/T 7714):
Xiao Mengjie,Zhang Tianbo,Cao Fei,et al.Anti-influenza properties of tiliroside isolated from Hibiscus mutabilis L[J].JOURNAL OF ETHNOPHARMACOLOGY.2023,303:doi:10.1016/j.jep.2022.115918.
APA:
Xiao, Mengjie,Zhang, Tianbo,Cao, Fei,Liang, Weihong,Yang, Yinhua...&Shaw, Pang-Chui.(2023).Anti-influenza properties of tiliroside isolated from Hibiscus mutabilis L.JOURNAL OF ETHNOPHARMACOLOGY,303,
MLA:
Xiao, Mengjie,et al."Anti-influenza properties of tiliroside isolated from Hibiscus mutabilis L".JOURNAL OF ETHNOPHARMACOLOGY 303.(2023)